| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3194712 | Clinics in Dermatology | 2012 | 5 Pages |
Abstract
Genetic and acquired bullous dermatoses can severely affect multiple domains of a patient's quality of life (QOL). Integrating formal evaluation of QOL into the clinical evaluation of patients facilitates an objective assessment of disease severity, mapping of disease trajectory, and captures therapeutic intervention outcomes. There have been 5 studies evaluating QOL in autoimmune dermatoses and 4 studies reviewing QOL in the genodermatoses. All literature to date indicates a significant disease burden in this setting. The development of formal QOL instruments has facilitated quantification of QOL deficits in this arena and offers promising tools for patient assessment in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Deshan F. Sebaratnam, James R. McMillan, Victoria P. Werth, Dédée F. Murrell,